Skip to content
MARKETS / BALCAO / CFOO
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP

China Foods Holdings Ltd. CFOO

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$327,871
▲ 40.5% YoY
$-398,672
In brief

What this company does

Substantially all of our operations are conducted in China, and are governed by Chinese laws, rules and regulations. Our health products are designed to help enhance immunity and improve general wellbeing. We provide the following categories of healthcare products, wine and customized healthcare consultation services in China: (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement (iv) Skincare and (v) wine. We also extend our service scope to provide personalized health consulting services to our clients, as well as consultancy services such as tailor-made natural food supplement solutions. We are focused on achieving long-term growth in revenues, cash flow and profit.

Written from the business description in China Foods Holdings Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 16 April 2026. Every sentence was checked against that document before publication.

Growth
USD 327,871.00
Revenue, FY2025 · full 19-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.3 · Net income -0.4
2.0M-0.2M-0.4M2007201020132016201920222025
Compound annual growth
−2.5%
−20.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −20.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−122 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -121.7% · Net -121.6%
50%100%-100%-200%2007201020132016201920222025
ROE
FY2022 · ROE -169.4%
-50%-100%-150%2007201020132016201920222025
Gross margin9.1%
Operating margin-121.7%
Net margin-121.6%
Return on assets-123.1%
EBITDAUSD -391,934.00

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $
FY2024 · FCF -377266.0
200000400000-200000-4000002007201020132016201920222025

Total assetsUSD 212,890.00
EquityUSD -1.3M
CashUSD 9,893.00
Current ratio0.11×

Equity funds -600% of total assets.

The 19-year record
19 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0···
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0·········
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.00.0············
Income tax $B·0.0·0.00.00.00.00.00.00.00.00.00.00.00.00.0···
Net income $B−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B·−0.0−0.0·−0.00.00.0············
EPS, diluted $−0.02−0.02−0.02−0.02−0.02−0.030.01−0.01−0.01−0.01−0.01−0.01−0.010.000.000.00···
Dividend / sh $···················
Payout %···················
ROE %···−169.4−73.7−42.112.0············
Shares out B0.020.020.020.020.020.020.010.010.010.010.010.010.010.010.010.010.010.010.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 19 of 19 fiscal years. 15 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2007

Share this section

Download image